Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Depamide
2. Dipropylacetamide
3. Valproic Acid Amide
1. 2-propylpentanamide
2. 2430-27-5
3. Depamide
4. Dipropylacetamide
5. 2,2-di-n-propylacetamide
6. Valpramide
7. 2-propylvaleramide
8. Pentanamide, 2-propyl-
9. 2-propylpentamide
10. 2-ethylvaleramide
11. Valpromide [inn]
12. Propyl-2 Valeramide
13. Valeramide, 2-propyl-
14. Mfcd00051534
15. Rua6cwu76g
16. Chebi:74562
17. Valpromide (inn)
18. Ncgc00182080-02
19. Depamid
20. Alpha-propylvaleramide
21. Valpromida
22. Valpromidum
23. Valpromidum [inn-latin]
24. Valpromida [inn-spanish]
25. Di-n-propylacetamide
26. Einecs 219-394-2
27. Unii-rua6cwu76g
28. Brn 1750444
29. Depamide (tn)
30. Di-n-propyl Acetamide
31. 1nu3
32. 3g0i
33. Valpromide [mi]
34. .alpha.-propylvaleramide
35. Dsstox_cid_3734
36. Valpromide [mart.]
37. Dsstox_rid_77172
38. Valpromide [who-dd]
39. Dsstox_gsid_23734
40. Schembl35392
41. Chembl93836
42. Zinc2238
43. Valpromide, >=97% (nmr)
44. Dtxsid1023734
45. Hms3886c09
46. Hy-b2117
47. Tox21_113134
48. S4991
49. Akos005068257
50. Ccg-266167
51. Cs-8176
52. Db04165
53. Ncgc00182080-03
54. Ncgc00182080-04
55. As-58130
56. Sy096545
57. Cas-2430-27-5
58. Ft-0609288
59. A16980
60. D02766
61. Valproic Acid Impurity F [ep Impurity]
62. 430d275
63. A817204
64. Q847560
65. Sr-01000944932
66. Sr-01000944932-1
67. W-107334
| Molecular Weight | 143.23 g/mol |
|---|---|
| Molecular Formula | C8H17NO |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 5 |
| Exact Mass | 143.131014166 g/mol |
| Monoisotopic Mass | 143.131014166 g/mol |
| Topological Polar Surface Area | 43.1 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 95.4 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
N - Nervous system
N03 - Antiepileptics
N03A - Antiepileptics
N03AG - Fatty acid derivatives
N03AG02 - Valpromide
Digital Content 
NEWS #PharmaBuzz
Global Sales Information
ABOUT THIS PAGE
A Valpromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Valpromide, including repackagers and relabelers. The FDA regulates Valpromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Valpromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Valpromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Valpromide supplier is an individual or a company that provides Valpromide active pharmaceutical ingredient (API) or Valpromide finished formulations upon request. The Valpromide suppliers may include Valpromide API manufacturers, exporters, distributors and traders.
click here to find a list of Valpromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Valpromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Valpromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Valpromide GMP manufacturer or Valpromide GMP API supplier for your needs.
A Valpromide CoA (Certificate of Analysis) is a formal document that attests to Valpromide's compliance with Valpromide specifications and serves as a tool for batch-level quality control.
Valpromide CoA mostly includes findings from lab analyses of a specific batch. For each Valpromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Valpromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Valpromide EP), Valpromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Valpromide USP).
LOOKING FOR A SUPPLIER?
